Search Results - Twitty, Christopher

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Disruption of TGF-β signaling prevents the generation of tumor-sensitized T-reg cells and facilitates therapeutic antitumor immunity

    Disruption of TGF-β signaling prevents the generation of tumor-sensitized T-reg cells and facilitates therapeutic antitumor immunity by Petrausch, Ulf, Jensen, Shawn, Twitty, Christopher, Poehlein, Christian, Haley, Daniel, Walker, Edwin, Fox, Bernard

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro

    Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro by Lin, Amy H., Twitty, Christopher G., Burnett, Ryan, Hofacre, Andrew, Mitchell, Leah A., Espinoza, Fernando Lopez, Gruber, Harry E., Jolly, Douglas J.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Increased Frequency of Suppressive Regulatory T Cells and T-cell Mediated Antigen Loss Results in Murine Melanoma Recurrence

    Increased Frequency of Suppressive Regulatory T Cells and T-cell Mediated Antigen Loss Results in Murine Melanoma Recurrence by Jensen, Shawn M., Twitty, Christopher G., Maston, Levi D., Antony, Paul A., Lim, May, Hu, Hong-Ming, Petrausch, Ulf, Restifo, Nicholas P., Fox, Bernard A.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Intratumoral plasmid IL-12 electroporation therapy in advanced melanoma patients induces systemic and intratumoral T cell responses: T cell responses induced by plasmid IL-12 electroporation

    Intratumoral plasmid IL-12 electroporation therapy in advanced melanoma patients induces systemic and intratumoral T cell responses: T cell responses induced by plasmid IL-12 elect... by Greaney, Samantha K., Algazi, Alain P., Tsai, Katy K., Takamura, Kathryn T., Chen, Lawrence, Twitty, Christopher G., Zhang, Li, Paciorek, Alan, Pierce, Robert H., Le, Mai H., Daud, Adil I., Fong, Lawrence

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity

    Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity by Lee, Jack Y., Nguyen, Bianca, Mukhopadhyay, Anandaroop, Han, Mia, Zhang, Jun, Gujar, Ravindra, Salazar, Jon, Hermiz, Reneta, Svenson, Lauren, Browning, Erica, Lyerly, H. Kim, Canton, David A., Fisher, Daniel, Daud, Adil, Algazi, Alain, Skitzki, Joseph, Twitty, Christopher G.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12

    Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 by Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina, Siwicki, Marie, Gungabeesoon, Jeremy, Freeman, Gordon J., Warren, Sarah E., Ong, SuFey, Browning, Erica, Twitty, Christopher G., Pierce, Robert H., Le, Mai H., Algazi, Alain P., Daud, Adil I., Pai, Sara I., Zippelius, Alfred, Weissleder, Ralph, Pittet, Mikael J.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Intratumoral plasmid IL-12 expands CD8(+) T cells and induces a CXCR3 gene signature in triple-negative breast tumors that sensitizes patients to anti-PD-1 therapy

    Intratumoral plasmid IL-12 expands CD8(+) T cells and induces a CXCR3 gene signature in triple-negative breast tumors that sensitizes patients to anti-PD-1 therapy by Telli, Melinda L., Nagata, Hiroshi, Wapnir, Irene, Acharya, Chaitanya R., Zablotsky, Kaitlin, Fox, Bernard A., Bifulco, Carlo B., Jensen, Shawn M., Ballesteros-Merino, Carmen, Le, Mai Hope, Pierce, Robert H., Browning, Erica, Hermiz, Reneta, Svenson, Lauren, Bannavong, Donna, Jaffe, Kim, Sell, Jendy, Foerter, Kellie Malloy, Canton, David A., Twitty, Christopher G., Osada, Takuya, Lyerly, H. Kim, Crosby, Erika J.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: